Completed OBSERVATIONAL NCT02602470

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea

Sponsor: Bayer

Conditions Rosacea

Interventions Azelaic Acid Cream Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) Brimonidine Tartrate Gel Metronidazole Emulsion Metronidazole Lotion Metronidazole cream Metronidazole gel

Updated 8 times since 2017 Last updated: Mar 30, 2020 Started: Jan 8, 2015 Primary completion: Mar 10, 2016 Completion: Mar 10, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Rosacea and is currently completed. Bayer leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
May 2020 — Jan 2021 [monthly]

Completed
Jun 2018 — May 2020 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jun 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Jun 2017 [monthly]

Completed NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer
LEO Pharma

Data source: LEO Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States